- increased neutrophil cell number / IMPC
- decreased locomotor activity / IMPC
- decreased hemoglobin content / IMPC
- increased circulating alanine transaminase level / IMPC
- decreased lean body mass / IMPC
- decreased lymphocyte cell number / IMPC
- increased circulating aspartate transaminase level / IMPC
- increased circulating glucose level / IMPC
- increased total body fat amount / IMPC
- increased freezing behavior / IMPC
C57BL/6NTac-Adora2aem1(IMPC)H/H
Status | Available to order |
EMMA ID | EM:12665 |
International strain name | C57BL/6NTac-Adora2aem1(IMPC)H/H |
Alternative name | |
Strain type | Endonuclease-mediated |
Allele/Transgene symbol | Adora2aem1(IMPC)H |
Gene/Transgene symbol | Adora2a |
Information from provider
Provider | MRC, Medical Research Council |
Provider affiliation | Mary Lyon Centre at MRC Harwell |
Genetic information | This mouse line originates from CRISPR zygote microinjection. For further details see the project page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- increased total body fat amount / IMPC
- increased circulating alanine transaminase level / IMPC
- decreased hemoglobin content / IMPC
- decreased lean body mass / IMPC
- increased circulating glucose level / IMPC
- decreased lymphocyte cell number / IMPC
- decreased locomotor activity / IMPC
- increased circulating aspartate transaminase level / IMPC
- increased neutrophil cell number / IMPC
- increased freezing behavior / IMPC
MGI phenotypes (gene matching)
- heart right ventricle hypertrophy / MGI
- abnormal pulmonary artery morphology / MGI
- increased aggression towards males / MGI
- increased anxiety-related response / MGI
- hypoactivity / MGI
- decreased exploration in new environment / MGI
- abnormal liquid preference / MGI
- abnormal cardiovascular system physiology / MGI
- increased thermal nociceptive threshold / MGI
- increased heart rate / MGI
- abnormal sclera morphology / MGI
- increased systemic arterial blood pressure / MGI
- vascular smooth muscle hypertrophy / MGI
- hypoalgesia / MGI
- myopia / MGI
- abnormal locomotor activation / MGI
- pulmonary hypertension / MGI
- nervous system phenotype / MGI
- abnormal lung vasculature morphology / MGI
- cardiovascular system phenotype / MGI
- vision/eye phenotype / MGI
- decreased cerebral infarction size / MGI
- decreased susceptibility to ischemic brain injury / MGI
- increased body mass index / MGI
- decreased interleukin-10 secretion / MGI
- decreased physiological sensitivity to xenobiotic / MGI
- increased platelet aggregation / MGI
- impaired behavioral response to addictive substance / MGI
- impaired behavioral response to alcohol / MGI
- increased right ventricle systolic pressure / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).